ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

ARWR Arrowhead Pharmaceuticals Inc

23,53
-1,16 (-4,70%)
Dernière mise à jour : 21:22:15
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 624 190
Prix Achat 23,52
Prix Vente 23,56
Actualités -
Maximum Haut 24,345

Bas
20,67

Sur 52 semaines

Haut
39,83

Minimum Bas 23,455
Nom Action Symbole Action Marché Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-1,16 -4,70% 23,53 21:22:15
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
24,27 23,455 24,345 24,69
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
10 832 624 190 US$ 23,84 US$ 14 880 040 - 20,67 - 39,83
Dernière Transaction Type Quantités échangées Prix transaction Devise
21:22:09 24 US$ 23,5321 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
2,93B 123,90M - 240,74M -205,28M -1,66 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Arrowhead Pharmaceuticals

Date Heure Source Titre
09/5/202422:11Edgar (US Regulatory)Form 8-K - Current report
07/5/202400:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/4/202415:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of..
08/3/202423:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
27/2/202423:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
06/2/202422:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/2/202422:07Edgar (US Regulatory)Form 8-K - Current report
02/2/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
26/1/202423:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
18/1/202400:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..

Forum Action Arrowhead Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Arrowhead Pharmaceuticals Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine22,8225,5022,5824,621 245 7210,713,11%
1 mois25,4826,0921,6523,811 167 082-1,95-7,65%
3 mois27,1629,9321,3924,841 005 969-3,63-13,37%
6 mois23,7939,8321,3929,691 334 891-0,26-1,09%
1 an36,1939,8320,6729,301 181 643-12,66-34,98%
3 ans76,2993,6620,6738,29953 555-52,76-69,16%
5 ans26,6593,6619,510142,901 111 958-3,12-11,71%

Dernières Valeurs Consultées

Delayed Upgrade Clock